PharmaCorp Rx Stock

PharmaCorp Rx Diluted EPS

The Diluted Earnings per Share of PharmaCorp Rx (PCRX.V) as of Sep 5, 2026 is -0.01 CAD. In the previous year, Diluted Earnings per Share was -0.01 CAD — a change of 5.98% (lower).

Diluted EPS

-0.01CAD

YoY

5.98%

Last updated:

Diluted Earnings per Share of PharmaCorp Rx is 2026 -0.01 CAD. Diluted Earnings per Share of PharmaCorp Rx was 2025 -0.01 CAD. It decreases by 5.98% lower compared to the previous year.

The PharmaCorp Rx Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2021
-0.00 CAD
Jan 1, 2022
-0.02 CAD
Jan 1, 2023
-0.01 CAD
Jan 1, 2024
-0.01 CAD
The PharmaCorp Rx Diluted EPS history
YEARDiluted EPSYoY
-0.01CAD+5.98%
-0.01CAD-26.42%
-0.02CAD+2,171.43%
-0.00CAD—
Access this data via the Eulerpool API
Get Free API Key

PharmaCorp Rx Stock analysis

What does PharmaCorp Rx do? PharmaCorp Rx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaCorp Rx stock

Diluted Earnings per Share of PharmaCorp Rx is -0.01 CAD in 2026.

Diluted Earnings per Share of PharmaCorp Rx changed from -0.01 CAD to -0.01 CAD, representing a 5.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — PharmaCorp Rx

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — PharmaCorp Rx